Kylie Morphett - Search Results

Year	Number of Results
2010	1
2013	1
2014	1
2015	2
2016	3
2017	2
2018	4
2019	6
2020	7
2021	4

1

Varenicline for smoking cessation in young people: is there more we need to know?

Morphett K, Connor JP. Morphett K, et al. Lancet Child Adolesc Health. 2020 Nov;4(11):797-799. doi: 10.1016/S2352-4642(20)30305-9. Epub 2020 Sep 25. Lancet Child Adolesc Health. 2020. PMID: 32979940 No abstract available.

2

Barriers and facilitators to switching from smoking to vaping: Advice from vapers.

Morphett K, Weier M, Borland R, Yong HH, Gartner C. Morphett K, et al. Drug Alcohol Rev. 2019 Mar;38(3):234-243. doi: 10.1111/dar.12907. Epub 2019 Feb 10. Drug Alcohol Rev. 2019. PMID: 30740790

3

Attitudes towards a hypothetical 'clean nicotine' product and harm reduction among smokers.

Morphett K, Puljević C, Borland R, Carter A, Hall W, Gartner C. Morphett K, et al. Int J Drug Policy. 2020 Nov 8;88:103020. doi: 10.1016/j.drugpo.2020.103020. Online ahead of print. Int J Drug Policy. 2020. PMID: 33161296

4

Nicotine vaping product use, harm perception and policy support among pharmacy customers in Brisbane, Australia.

Erku DA, Gartner CE, Tengphakwaen U, Morphett K, Steadman KJ. Erku DA, et al. Among authors: morphett k. Drug Alcohol Rev. 2019 Sep;38(6):703-711. doi: 10.1111/dar.12984. Epub 2019 Sep 4. Drug Alcohol Rev. 2019. PMID: 31486151

5

How are nicotine vaping products represented to pharmacists? A content analysis of Australian pharmacy news sources.

Erku DA, Zhang R, Gartner CE, Morphett K, Steadman KJ. Erku DA, et al. Among authors: morphett k. Int J Pharm Pract. 2020 Aug;28(4):390-394. doi: 10.1111/ijpp.12623. Epub 2020 Apr 20. Int J Pharm Pract. 2020. PMID: 32311165

6

Commentary on Notley et al. : Understanding transitions in the use of nicotine and tobacco products-the value of qualitative longitudinal research.

Morphett K. Morphett K. Addiction. 2021 Mar;116(3):606-607. doi: 10.1111/add.15307. Epub 2020 Nov 26. Addiction. 2021. PMID: 33241632 No abstract available.

7

The medium is not the message: A content analysis of public information about vaping product regulations in Australia.

Saw KES, Morphett K, Puljević C, Bromberg M, Gartner C. Saw KES, et al. Among authors: morphett k. Drug Alcohol Rev. 2019 Jul;38(5):569-578. doi: 10.1111/dar.12961. Epub 2019 Jun 26. Drug Alcohol Rev. 2019. PMID: 31243826

8

Nicotine vaping products as a harm reduction tool among smokers: Review of evidence and implications for pharmacy practice.

Erku D, Gartner CE, Morphett K, Snoswell CL, Steadman KJ. Erku D, et al. Among authors: morphett k. Res Social Adm Pharm. 2020 Sep;16(9):1272-1278. doi: 10.1016/j.sapharm.2020.02.002. Epub 2020 Feb 8. Res Social Adm Pharm. 2020. PMID: 32061550

9

Beliefs and Self-reported Practices of Health Care Professionals Regarding Electronic Nicotine Delivery Systems: A Mixed-Methods Systematic Review and Synthesis.

Erku DA, Gartner CE, Morphett K, Steadman KJ. Erku DA, et al. Among authors: morphett k. Nicotine Tob Res. 2020 Apr 21;22(5):619-629. doi: 10.1093/ntr/ntz046. Nicotine Tob Res. 2020. PMID: 30938442

10

Predicting vaping uptake, vaping frequency and ongoing vaping among daily smokers using longitudinal data from the International Tobacco Control (ITC) Four Country Surveys.

Chan G, Morphett K, Gartner C, Leung J, Yong HH, Hall W, Borland R. Chan G, et al. Among authors: morphett k. Addiction. 2019 Oct;114 Suppl 1:61-70. doi: 10.1111/add.14537. Epub 2019 Jan 21. Addiction. 2019. PMID: 30575153

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results